Abstract
To test the hypothesis that nitric oxide (NO) buffers the renal vasoconstrictor effects of endothelin-1 (ET-1) early in life, renal haemodynamic responses to ET-1 were measured in the presence and absence of endogenously produced NO in conscious lambs. Renal haemodynamic effects of ET-1 were measured for 5 min before (control) and 20 min after intraarterial injection of ET-1 before and after pretreatment with 20 mg/kg of the l-arginine analogue NG-nitro-l-arginine methyl ester (l-NAME), (experiment 1) and its inactive isomer D-NAME (experiment 2) in conscious lambs aged ~1 week (N=7) and ~6 weeks (N=6). The two experiments were carried out in random order at intervals of 24–48 h. In lambs aged ~6 weeks, a marked increase in renal vascular resistance (RVR) was elicited by ET-1 administration; this response was enhanced twofold following pretreatment with l-NAME. In 1-week-old lambs, however, an increase in RVR in response to ET-1 occurred only after pretreatment with l-NAME. Therefore, we accept our hypothesis and conclude that NO buffers the renal vasoconstrictor effects of ET-1 early in life.
Similar content being viewed by others
References
Yanagisawa M, Kurihara H, Kimura S, et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415
Webb DJ (1997) Endothelin: from molecule to man. Br J Pharmacol 44:9–20
King AJ, Brenner BM, Anderson S (1989) Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 256:F1051-F1058
Eriksson S, Andersson B, Gunnarsson U, Rundgren M (1994) Hypertension and thirst outlasting renal vasoconstriction as effects of a brief elevation of systemic angiotensin II in sheep. Acta Physiol Scand 150:181–188
Chou S-Y, Porush JG (1995) Renal actions of endothelin-1 and endothelin-3: Interactions with the prostaglandin system and nitric oxide. Am J Kidney Dis 26:116–123
Smith FG, Nohara N, Patel A, Sener A (2002) Endothelin-1 (ET-1) produces no renal vasoconstriction in conscious newborn lambs. Pediatr Nephrol 17:889–895
Abadie L, Blazy I, Roubert P, et al. (1996) Decrease in endothelin-1 renal receptors during the 1st month of life in the rat. Pediatr Nephrol 10:185–189
Becker K, Erdbrügger W, Heinroth-Hoffmann I, et al. (1996) Endothelin-induced inositol phophate formation in rat kidney. Studies on receptor subtypes, G-proteins and regulation during ontogenesis. Naunyn-Schmiedeberg’s Arch Pharmacol 354:572–578
Hocher B, Rohmeiss P, Dickmann F, et al. (1995) Distribution of endothelin receptor subtypes in the rat kidney. Renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan. Eur J Clin Chem Clin Biochem 33:463–472
Docherty CC, Kalmar-Nagy J, Engelen M, Nathanielsz PW (2001) Development of fetal vascular responses to endothelin-1 and acetylcholine in the sheep. Am J Physiol Regul Integr Comp Physiol 280:R554-R562
Sener A, Smith FG (1999) Acetylcholine chloride and renal haemodynamics during postnatal maturation in conscious lambs. J Appl Physiol 87:1296–1300
Török J, Gerová M (1997) Developmental dynamics of endothelial and neurogenic control of canine thoracic aorta. Mech Ageing Devel 95:143–152
Sener A, Smith FG (2001) Renal hemodynamic effects of l-NAME during postnatal maturation in conscious lambs. Pediatr Nephrol 16:868–873
Sener A, Smith FG (2002) Glomerular and tubular responses to NG-nitro-l-arginine methyl ester are age-dependent in conscious lambs. Am J Physiol Regul Integr Comp Physiol 282:R1512-R1520
Sener A, Smith FG (1999) Dose dependent effects of nitric oxide synthase inhibition on systemic and renal haemodynamics in conscious lambs. Can J Physiol Pharmacol 77:1–7
Solhaug MJ, Ballèvre L, Guignard J-P, et al. (1996) Nitric oxide in the developing kidney. Pediatr Nephrol 10:529–539
de Wildt SN, Smith FG (1997) Effects of the angiotensin converting enzyme (ACE) inhibitor, captopril, on the cardiovascular, endocrine and renal responses to furosemide in conscious lambs. Can J Physiol Pharmacol 75:263–270
Yanagisawa M, Inoue A, Ishikawa T, et al. (1988) Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 85:6964–6967
King AJ, Brenner BM (1992) Renal and systemic hemodynamic actions of endothelin. In: Rubanyi GM (ed) Endothelin. Oxford University Press, New York, pp 158–178
Ahlborg G, Ottosson-Seeberger A, Hemsen A, Lundberg JM (1994) Big ET-1 infusion in man causes renal ET-1 release, renal and splanchnic vasoconstriction, and increased mean arterial blood pressure. Cardiovasc Res 28:1559–1563
Miller WL, Redfield MM, Burnett Jr JC (1989) Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 83:317–320
Katoh T, Chang H, Uchida S, et al. (1990) Direct effects of endothelin in the rat kidney. Am J Physiol 258:F397-F402
Yokokawa K, Kohno M, Murakawa K, et al. (1989) Acute effects of endothelin on renal hemodynamics and blood pressure in anesthetized rats. Am J Hypertens 2:715–717
Pernow J, Boutier,J-F, Franco-Cereceda A, et al. (1988) Potent selective vasoconstrictor effects of endothelin in the pig kidney in vivo. Acta Physiol Scand 134:573–574
Hirata Y, Matsuoka H, Kimura K, et al. (1989) Renal vasoconstriction by the endothelial cell-derived peptide endothelin in spontaneously hypertensive rats. Circ Res 65:1370–1379
Pernow JP, Hemsen A, Lundberg JM (1989) Tissue specific distribution, clearance and vascular effects of endothelin in the pig. Biochem Biophys Res Commun 161:647–653
Anggard E, Galton S, Rae G, et al. (1989) The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharmacol 13:S46-S49
Warner TD (1999) Relationships between the endothelin and nitric oxide pathways. Clin Exp Pharmacol Physiol 26:247–252
Vanhoutte PM (2000) Say NO to ET. J Auton Nerv Syst 81:271–277
Wiley KE, Davenport AP (2001) Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system. Br J Pharmacol 132:213–220
La M, Reid JJ (1995) Endothelin-1 and the regulation of vascular tone. Clin Exp Pharmacol Physiol 22:315–322
Lüscher TF, Yong Z, Tschudi M, et al. (1990) Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 66:1088–1094
Garcia JL, Fernandez N, Garcia-Villalon AL, et al. (1996) Coronary vasoconstriction by endothelin-1 in anesthetized goats: role of endothelin receptors, nitric oxide and prostanoids. Eur J Pharmacol 315:179–186
Baylis C (1999) Acute interactions between endothelin and nitric oxide in the control of renal hemodynamics. Clin Exp Pharmacol Physiol 26:253–257
Lin H, Smith Jr. MJ, Young DB (1996) Roles of prostaglandins and nitric oxide in the effect of endothelin-1 on renal hemodynamics. Hypertension 28:372–378
Cairns HS, Rogerson ME, Fairbanks LD, et al. (1989) Endothelin induces an increase in renal vascular resistance and a fall in glomerular filtration rate in the rabbit isolated perfused kidney. Br J Pharmacol 98:155–160
Rogerson ME, Cairns HS, Fairbanks LD, et al. (1993) Endothelin-1 in the rabbit: interactions with cyclo-oxygenase and NO-synthase products. Br J Pharmacol 108:838–843
Madeddu P, Anania V, Parpaglia PP, et al. (1991). Endothelin-1 induced renal vasoconstriction is blunted by enalaprilat and enhanced by EDRF antagonist in awake normotensive rats. Clin Invest Med 14:600–606
Gellai M, de Wolf R, Fletcher T, Nambi P (1997) Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of nitric oxide. Pharmacology 55:299–308
Le Monnier de Gouville AC, Lippton H, Hyman A, Cavero I (1989) NG-monomethyl-l-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats. Eur J Pharmacol 171:237–240
Ovadia B, Bekker JM, Fitzgerald RK, et al. (2002) Nitric oxide-endothelin-1 interactions after acute ductal constriction in fetal lambs. Am J Physiol Heart Circ Physiol 282:H862-H871
Perreault T, De Marte J (1993) Maturational changes in endothelium-derived relaxations in newborn piglet pulmonary circulation. Am J Physiol Heart Circ Physiol 264:H302-H309
Bogaert GA, Kogan BA, Mevorach RA, et al. (1996) Exogenous endothelin-1 causes renal vasodilation in the fetal lamb. J Urol 156:847–853
Acknowledgements
A portion of this work was presented as a poster at the annual meetings for Experimental Biology 2002 and published in the proceedings [Smith FG, van der Velde L, Sener A (2002) Nitric oxide buffers renal vasoconstrictor effects of endothelin-1 in conscious newborn lambs. FASEB J 15:A331]. Operating grants provided by the Canadian Institutes for Health Research and the Kidney Foundation of Canada supported this research. During the tenure of these experiments, Dr. Francine G. Smith was a Heritage Medical Senior Scholar supported by the Alberta Heritage Foundation for Medical Research, and Dr. Alp Sener was supported by a PMAC/MRC graduate studentship.
Author information
Authors and Affiliations
Corresponding author
Additional information
The current address of Dr. Liesbeth van der Velde is UCLA Medical Center, Los Angeles, CA, USA. The current address of Dr. Alp Sener is University of Western Ontario, London, ON, Canada
Rights and permissions
About this article
Cite this article
Smith, F.G., van der Velde, L. & Sener, A. Nitric oxide modulates renal vasoconstrictor effect of endothelin-1 in conscious lambs. Pediatr Nephrol 20, 1545–1551 (2005). https://doi.org/10.1007/s00467-005-2015-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-005-2015-5